Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges

Area of Science:

• Occupational Health
• Genomics in the Workplace
• Employee Wellness Programs

Background:

• Workplace genetic and/or genomic testing (wGT) is an emerging benefit within voluntary employer wellness programs.
• Limited data exists on the prevalence and specific types of wGT offered by companies.
• Understanding employer adoption is crucial for evaluating this benefit's reach.

Purpose of the Study:

• To determine the prevalence and distribution of wGT in U.S. companies' wellness programs.
• To identify the types of genetic and/or genomic testing offered.
• To assess employer perspectives on offering wGT.

Main Methods:

• Conducted a landscaping review of U.S. companies.
• Analyzed publicly available company information.
• Administered national surveys and conducted interviews with company representatives.

Main Results:

• Public data indicated 11.9% of investigated companies offered wGT.
• Weighted survey data suggests approximately 1% of all U.S. companies offer wGT.
• Information gathering proved challenging, indicating potential underreporting.

Conclusions:

• Broad uptake of wGT in U.S. workplaces is not evident.
• The actual prevalence of wGT is likely low, despite some public claims.
• Further research is needed to overcome data collection challenges.